우리나라의 아토피 피부염으로 인한 경제적 비용 산출

This study aims to estimate the economic cost due to atopic dermatitis in Korea. The national patient sample data (NPS) of Health Insurance Review and Assessment Service (HIRA) was used to measure the cost of illness due to atopic dermatitis, and this study included both direct and indirect costs. Direct cost is composed of treatment, medication, transportation, and caregiver’s time cost. Indirect costs associated with the loss of productivity in atopic dermatitis patients, such as absence of work, income loss due to premature death in the future. The results show that the socio-economic burden of atopic dermatitis is about 90 billion won in Korea. Furthermore, this study identified that children and adolescents are more vulnerable. The results of this study can be valuable for determining the priority of health policy and intervention strategies to reduce the burden of disease due to atopic dermatitis.